How Much Did ScreenIn3D Raise?
Funding & Key Investors

ScreenIn3D, a UK-based biotechnology firm, has secured $1M in total capital, with its most recent funding round bringing in $1M through a major strategic investment. This significant backing underscores the company's progress in advanced lab-on-a-chip technologies aimed at accelerating cancer drug discovery.

What is ScreenIn3D?

ScreenIn3D
Business ServicesResearch & Development

ScreenIn3D operates at the intersection of biotechnology and advanced materials science, focusing on the development of innovative lab-on-a-chip technologies. These platforms are designed to revolutionize the process of cancer drug discovery by providing more efficient and accurate screening methods. The company's technology aims to reduce the time and cost associated with bringing new cancer therapies to market, positioning it as a key player in the competitive biotech landscape.

How much funding has ScreenIn3D raised?

ScreenIn3D has raised a total of $1M across 1 funding round:

2025

Seed

$1M

Seed (2025): $1M with participation from University of Strathclyde Glasgow, The TRICAPITAL Syndicate, Gabriel Investments, and Nidobirds Ventures

Key Investors in ScreenIn3D

University of Strathclyde Glasgow

University of Strathclyde Glasgow is an academic institution likely contributing research expertise and potentially early-stage funding to biotechnology ventures.

The TRICAPITAL Syndicate

The TRICAPITAL Syndicate is a business angel group focused on investing in growth-stage companies, particularly within Scotland, suggesting a strategic interest in scaling innovative businesses like ScreenIn3D.

Gabriel Investments

Gabriel Investments is an investment group that supports early-stage technology companies, particularly those post-revenue, indicating a focus on companies with proven traction and growth potential.

What's next for ScreenIn3D?

The recent major strategic investment signals a pivotal growth phase for ScreenIn3D, likely enabling the company to scale its operations, expand its research and development capabilities, and potentially accelerate the commercialization of its proprietary technologies. This enterprise-level funding suggests confidence from investors in ScreenIn3D's long-term vision and its potential to make a substantial impact on cancer treatment paradigms. The company is poised to leverage this capital to further solidify its market position and drive innovation in drug discovery.

See full ScreenIn3D company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesHuman Resources Management Systems (HRMS)Accounting for Legal Practices
Advertising NetworksBusiness Services
Business ServicesSoftware Testing
Business ServicesProject Management

Frequently Asked Questions Regarding ScreenIn3D Financial Insights

What are the most recent funding rounds that ScreenIn3D has completed, and what were the funding rounds?
ScreenIn3D has recently completed 1 funding rounds: Seed on Jun 11, 2025.
What is the total amount of funding ScreenIn3D has raised to date?
ScreenIn3D has raised a total of $1M in funding to date.
How many funding rounds has ScreenIn3D completed?
ScreenIn3D has completed 1 funding rounds.
How much funding did ScreenIn3D raise in its most recent funding round?
ScreenIn3D raised $1M in its most recent funding round.
Who are the lead investors in ScreenIn3D's latest funding round?
The lead investor in ScreenIn3D's latest funding round was University of Strathclyde Glasgow. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in ScreenIn3D's history?
The largest funding round in ScreenIn3D's history was $1M.
See more information about ScreenIn3D